SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-015030
Filing Date
2022-11-10
Accepted
2022-11-10 16:31:21
Documents
57
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tenx_10q.htm   iXBRL 10-Q 731510
2 CERTIFICATION tenx_ex311.htm EX-31.1 11923
3 CERTIFICATION tenx_ex312.htm EX-31.2 13114
4 CERTIFICATION tenx_ex321.htm EX-32.1 6032
5 CERTIFICATION tenx_ex322.htm EX-32.2 5852
  Complete submission text file 0001654954-22-015030.txt   3459662

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tenx-20220930.xsd EX-101.SCH 43032
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tenx-20220930_lab.xml EX-101.LAB 227621
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tenx-20220930_cal.xml EX-101.CAL 35170
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tenx-20220930_pre.xml EX-101.PRE 189596
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tenx-20220930_def.xml EX-101.DEF 92273
51 EXTRACTED XBRL INSTANCE DOCUMENT tenx_10q_htm.xml XML 429259
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34600 | Film No.: 221377815
SIC: 2834 Pharmaceutical Preparations